These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1204255)

  • 1. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
    Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
    Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH; Eife RF; Kalden JR
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
    Fidler IJ; Gersten DM; Budmen MB
    Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human malignant melanoma cells: morphological and immunological variations.
    Hakim AA
    Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N; Heuze F; Diez E; Jotereau F
    Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytotoxicity of the lymphocytes of melanoma patients against autologous tumor cells and its in vitro enhancement].
    Bykovskaia SN; Iobadze MS; Kupriianova TA; Demidov LV
    Biull Eksp Biol Med; 1987 Jan; 103(1):86-9. PubMed ID: 2948576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a chimpanzee anti-human melanoma antiserum.
    Stuhlmiller GM; Seigler HF
    Cancer Res; 1975 Aug; 35(8):2132-7. PubMed ID: 1149027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
    Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
    Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic index in melanoma patients].
    Sviatukhin MV; Razmakhnina NG; Lysenkova EM
    Vopr Onkol; 1977; 23(11):14-8. PubMed ID: 595509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.